Live feed
Filing
SC 13D/A
SC 13D/A0001571049-15-010129·Celgene Rivot Ltd
Schedule 13D ownership disclosure
Juno Therapeutics, Inc.
Security class unavailable · CUSIP: 48205A109
Event date: 2015-12-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001571049-15-010129
- Form type
- SC 13D/A
- Filer
- Celgene Rivot Ltd
- CIK
- CIK 1646600
- Filed
- Dec 21, 2015
- Reporting period
- Dec 21, 2015
- Description
- Schedule 13D beneficial ownership